Cardionovum

Be up
to date.

Latest press release

Globally first patient treated with LEGFLOW 018 in MOL, Belgium

Dr. Berghmans and Dr. van Bouckenooghe were the worldwide first users of the LEGFLOW 018 on a Patient with CLI disease. The product was used in BtK and showed excellent performance. In addition the patient received a DCB therapy with our LEGFLOW OTW in the SFA as well.

Learn more >>

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

CARDIONOVUM GmbH today announced the completion of enrollment of the RAPID trial. Results will be used to further support the safety and effectiveness of CARDIONOVUM’s Legflow® drug-coated balloon (DCB).

Learn more >>

Cardionovum announces enrollment of first patient in MAGNIFICENT trial

CARDIONOVUM GmbH, a medical technology company developing and commercializing innovative medical devices such as drug-coated balloons and drug-eluting stents for the treatment of coronary and peripheral artery disease, announced today the enrollment of the first patient in the MAGNIFICENT trial.

Learn more >>

RESTORE clinical study results on in-stent restenosis.

Cardionovum experiences increase in demand for its innovative, and next generation „RESTORE Paclitaxel-releasing coronary balloon dilatation catheter.“ The American Journal of Cardiology, issue December 2015, published study results on the efficacy and safety of Paclitaxel coated balloon catheters for the treatment of in-stent restenosis in high risk patients. The RESTORE DEB showed significant superiority with lowest incidence of restenosis, if compared to other contemporary coronary DEBs.

Learn more >>

Cardionovum at LINC 2016

Dr. Jean Paul de Vries (PI) presented the patient study results of the multi-center randomized RAPID trial.

Learn more >>

Early APERTO patient results look promising.

Cardionovum prepares for a first international publication on 6-12 months FU patient results from the ongoing APERTO clinical study program. The APERTO Paclitaxel-releasing high pressure shunt balloon dilatation catheter was exclusively designed to treat shunt stenosis of hemodialysis patients.

Learn more >>

Upcoming events

Cardionovum at CIRSE annual meeting

Cardionovum participates at CIRSE meeting.

Date: Sep 16, 2017 – Sep 20, 2017

Location: Copenhagen, Denmark

Visit website >>

Latest events

Cardionovum at SCR’17

Cardionovum participates at the Swiss Congress of Radiology SCR’17 Bern.

Date: June 08, 2017 – June 10, 2017

Location: Kursaal Bern, Switzerland

Visit website >>

Cardionovum EuroPCR exclusive event

Cardionovum customers deserve the best.
Exclusive Cardionovum event at EuroPCR 2017.

Date: May 17, 2017

Location: Maison de l'amérique latine, Paris, France

Learn more >>

Visit website >>

Cardionovum at Charing Cross

Cardionovum participates at Charing Cross.
You are welcome to visit us at booth no. 218.

Date: Apr 25, 2017 – Apr 28, 2017

Location: London, UK

Learn more >>

Visit website >>

Cardionovum at LINC

Cardionovum participates at LINC Leipzig Interventional Course

Date: Jan 24, 2017 – Jan 27, 2017

Location: Leipzig, Germany

Visit website >>

Cardionovum at CIRSE

Cardionovum participates at CIRSE

Date: Sep 09, 2016 – Sep 13, 2016

Location: Barcelona, Spain

Visit website >>

Cardionovum at EuroPCR

Cardionovum participates at EuroPCR

Date: May 16, 2016 – May 19, 2016

Location: Paris, France

Visit website >>

Cardionovum at Charing Cross

Cardionovum participates at Charing Cross

Date: Apr 25, 2016 – Apr 28, 2016

Location: London, UK

Visit website >>

Cardionovum at LINC

Cardionovum participates at LINC Leipzig Interventional Course

Date: Jan 25, 2016 – Jan 28, 2016

Location: Leipzig, Germany

Learn more >>

Visit website >>